In addition, SPEN mutations have also been reported in diffuse large B-cell lymphoma (DLBCL) [21], splenic marginal zone lymphoma (SMZL) [22, 23], and pancreatic carcinoma [24]. This evidence concerns the gene SPEN and splenic marginal zone lymphoma.